Clinical outcomes and emergence of resistance of Pseudomonas aeruginosa infections treated with ceftolozane-tazobactam versus ceftazidime-avibactam.
Antimicrob Agents Chemother
; : e0090724, 2024 Sep 04.
Article
in En
| MEDLINE
| ID: mdl-39230311
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Antimicrob Agents Chemother
Year:
2024
Document type:
Article
Affiliation country:
United States
Country of publication:
United States